Loading clinical trials...
Loading clinical trials...
Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed
Pain control after weight loss surgery is challenging due to the alteration of digestive system anatomy and limitation on using medications which can either be crushed or in liquid form for the first 10 days to 14 days after surgery. Additionally there are multiple programs in place to eliminate the use of narcotic/opioid based pain medications due their potential addictive risks. This study compares two groups of patients whom will have Roux en Y Gastric Bypass Surgery at UC Davis Medical Center, the control group will receive standard of care pain control medications (including opioid based medications) compared to the research arm, this group will receive Gabapentinin and Tylenol for pain control after surgery with rescue pain medications available if needed. Post surgery both groups will be managed by the Bariatric Surgery Team and will be contacted periodically as part of the standard of care to monitor pain control and usage of any rescue medications (if needed).
Age
35 - 65 years
Sex
FEMALE
Healthy Volunteers
No
UC Davis Health
Sacramento, California, United States
Start Date
January 20, 2021
Primary Completion Date
June 24, 2026
Completion Date
June 24, 2026
Last Updated
August 8, 2025
60
ACTUAL participants
Neurontin
DRUG
Dilaudid Injectable Product
DRUG
Marcaine Injectable Product
DRUG
Oxycodone Hydrochloride
DRUG
Hycet 7.5Mg-325Mg/15Ml Solution
DRUG
Zofran Injection
DRUG
Scopolamine patch
DRUG
Ativan
DRUG
Flexeril Oral Product
DRUG
Tylenol Suspension
DRUG
Lead Sponsor
University of California, Davis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04246463